MA50383A - Agents thérapeutiques pour maladies neurodégénératives - Google Patents
Agents thérapeutiques pour maladies neurodégénérativesInfo
- Publication number
- MA50383A MA50383A MA050383A MA50383A MA50383A MA 50383 A MA50383 A MA 50383A MA 050383 A MA050383 A MA 050383A MA 50383 A MA50383 A MA 50383A MA 50383 A MA50383 A MA 50383A
- Authority
- MA
- Morocco
- Prior art keywords
- therapeutic agents
- neurodegenerative diseases
- neurodegenerative
- diseases
- therapeutic
- Prior art date
Links
- 239000003814 drug Substances 0.000 title 1
- 208000015122 neurodegenerative disease Diseases 0.000 title 1
- 229940124597 therapeutic agent Drugs 0.000 title 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
- A61K31/19—Carboxylic acids, e.g. valproic acid
- A61K31/195—Carboxylic acids, e.g. valproic acid having an amino group
- A61K31/197—Carboxylic acids, e.g. valproic acid having an amino group the amino and the carboxyl groups being attached to the same acyclic carbon chain, e.g. gamma-aminobutyric acid [GABA], beta-alanine, epsilon-aminocaproic acid or pantothenic acid
- A61K31/198—Alpha-amino acids, e.g. alanine or edetic acid [EDTA]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/13—Amines
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
- A61P25/16—Anti-Parkinson drugs
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
Landscapes
- Health & Medical Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Veterinary Medicine (AREA)
- Chemical & Material Sciences (AREA)
- Public Health (AREA)
- Life Sciences & Earth Sciences (AREA)
- Medicinal Chemistry (AREA)
- Animal Behavior & Ethology (AREA)
- Pharmacology & Pharmacy (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Biomedical Technology (AREA)
- Neurology (AREA)
- Neurosurgery (AREA)
- Engineering & Computer Science (AREA)
- Organic Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Epidemiology (AREA)
- Psychology (AREA)
- Hospice & Palliative Care (AREA)
- Psychiatry (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201762574137P | 2017-10-18 | 2017-10-18 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| MA50383A true MA50383A (fr) | 2020-08-26 |
Family
ID=66174216
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| MA050383A MA50383A (fr) | 2017-10-18 | 2018-02-15 | Agents thérapeutiques pour maladies neurodégénératives |
Country Status (14)
| Country | Link |
|---|---|
| US (1) | US11793782B2 (fr) |
| EP (1) | EP3697399A1 (fr) |
| JP (1) | JP2021500342A (fr) |
| KR (1) | KR102549684B1 (fr) |
| CN (1) | CN111542314B (fr) |
| AU (1) | AU2018351709B2 (fr) |
| BR (1) | BR112020007657A2 (fr) |
| CA (1) | CA3079194A1 (fr) |
| IL (1) | IL273929A (fr) |
| MA (1) | MA50383A (fr) |
| MX (1) | MX2020003427A (fr) |
| RU (1) | RU2763425C2 (fr) |
| SG (1) | SG11202003390UA (fr) |
| WO (1) | WO2019078915A1 (fr) |
Families Citing this family (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| GB201709459D0 (en) | 2017-06-14 | 2017-07-26 | Intrabio Ltd | Treatment for migraine |
| CN111712239A (zh) * | 2018-02-15 | 2020-09-25 | 内在生物技术有限公司 | 治疗不宁腿综合征的治疗剂 |
Family Cites Families (9)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| ZA200507322B (en) * | 2003-03-06 | 2007-03-28 | Celgene Corp | Selective cytokine inhibitory drugs for treating disorders of the central nervous system |
| RU2458049C2 (ru) * | 2003-09-17 | 2012-08-10 | Ксенопорт, Инк. | Лечение или предупреждение синдрома беспокойных ног с использованием пролекарств аналогов гамк |
| KR101690390B1 (ko) * | 2007-05-11 | 2016-12-27 | 토마스 제퍼슨 유니버시티 | 신경변성 질환 및 장애의 치료 및 예방 방법 |
| EP2289886A1 (fr) * | 2009-08-31 | 2011-03-02 | Institut d'Investigacions Biomédiques August PI I Sunyer | Peptoides agonistes du facteur de croissance nerveuse et leur utilisation en tant que médicaments |
| CA2785056A1 (fr) * | 2009-12-22 | 2011-07-21 | Pondera Biotechnologies, LLC | Methodes et compositions pour le traitement de la detresse dysfonctionnelle et l'augmentation de la securite et de l'efficacite de medicaments specifiques |
| TN2010000251A1 (fr) * | 2010-06-03 | 2011-11-11 | Rekik Raouf | N-acetyl-dl-leucine medicament neuro et retino protecteur |
| KR20240068752A (ko) | 2010-06-25 | 2024-05-17 | 샤이어 휴먼 지네틱 테라피즈 인크. | 치료제들의 cns 전달 |
| US10045948B2 (en) * | 2014-02-27 | 2018-08-14 | Medrx Co., Ltd. | Pramipexole-containing transdermal patch for treatment of neurodegenerative disease |
| SI3416631T1 (sl) * | 2016-08-11 | 2019-09-30 | Intrabio Ltd | Terapevtska sredstva za nevrodegenerativne bolezni |
-
2018
- 2018-02-15 MX MX2020003427A patent/MX2020003427A/es unknown
- 2018-02-15 BR BR112020007657-0A patent/BR112020007657A2/pt unknown
- 2018-02-15 SG SG11202003390UA patent/SG11202003390UA/en unknown
- 2018-02-15 KR KR1020207014143A patent/KR102549684B1/ko active IP Right Grant
- 2018-02-15 JP JP2020521938A patent/JP2021500342A/ja active Pending
- 2018-02-15 CN CN201880081672.6A patent/CN111542314B/zh active Active
- 2018-02-15 CA CA3079194A patent/CA3079194A1/fr active Pending
- 2018-02-15 AU AU2018351709A patent/AU2018351709B2/en active Active
- 2018-02-15 RU RU2020115710A patent/RU2763425C2/ru active
- 2018-02-15 US US16/756,948 patent/US11793782B2/en active Active
- 2018-02-15 WO PCT/US2018/018420 patent/WO2019078915A1/fr unknown
- 2018-02-15 EP EP18708286.2A patent/EP3697399A1/fr active Pending
- 2018-02-15 MA MA050383A patent/MA50383A/fr unknown
-
2020
- 2020-04-12 IL IL273929A patent/IL273929A/en unknown
Also Published As
| Publication number | Publication date |
|---|---|
| CA3079194A1 (fr) | 2019-04-25 |
| RU2020115710A3 (fr) | 2021-11-18 |
| RU2020115710A (ru) | 2021-11-18 |
| BR112020007657A2 (pt) | 2020-09-29 |
| AU2018351709B2 (en) | 2024-01-04 |
| KR20200074170A (ko) | 2020-06-24 |
| US20210196659A1 (en) | 2021-07-01 |
| RU2763425C2 (ru) | 2021-12-29 |
| CN111542314A (zh) | 2020-08-14 |
| IL273929A (en) | 2020-05-31 |
| AU2018351709A1 (en) | 2020-05-07 |
| US11793782B2 (en) | 2023-10-24 |
| SG11202003390UA (en) | 2020-05-28 |
| CN111542314B (zh) | 2023-11-24 |
| EP3697399A1 (fr) | 2020-08-26 |
| KR102549684B1 (ko) | 2023-06-29 |
| WO2019078915A1 (fr) | 2019-04-25 |
| JP2021500342A (ja) | 2021-01-07 |
| MX2020003427A (es) | 2020-09-14 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| GB201820166D0 (en) | Therapeutic agents | |
| MA47521A (fr) | Agents thérapeutiques pour maladies neurodégénératives | |
| GB201820165D0 (en) | Therapeutic agents | |
| GB201709456D0 (en) | Therapeutic agents | |
| DK3463465T3 (da) | Exosomer omfattende terapeutiske polypeptider | |
| SI3600309T1 (sl) | Terapevtske kombinacije za zdravljenje bolezni jeter | |
| MA48996A (fr) | Méthodes de traitement de maladies neurodégénératives | |
| GB201603104D0 (en) | Therapeutic agents | |
| GB201805816D0 (en) | Therapeutic agents | |
| DK3870578T3 (da) | Terapeutiske forbindelser | |
| MA53568A (fr) | Médicaments pour le traitement de maladies ophtalmiques | |
| ZA201902689B (en) | Therapeutic protein | |
| IL281869A (en) | Medical factor for neurodegenerative disease | |
| IL273929A (en) | Therapeutic agents for neurodegenerative diseases | |
| GB201700553D0 (en) | Therapeutic agents | |
| MA54630A (fr) | N,n-bis-2-mercaptoéthyle isophtalamide pour le traitment des maladies neurodégénératives | |
| GB201600376D0 (en) | Novel therapeutic agents | |
| GB201820168D0 (en) | Therapeutic agents | |
| GB201820160D0 (en) | Therapeutic agents | |
| GB201820172D0 (en) | Therapeutic agents | |
| GB201820162D0 (en) | Therapeutic agents | |
| GB201820164D0 (en) | Therapeutic agents | |
| GB201820170D0 (en) | Therapeutic agents | |
| GB201811753D0 (en) | Therapeutic agents | |
| GB201811467D0 (en) | Therapeutic agents |